Medicamen Biotech Limited has informed the Exchange about Copy of Newspaper Publication

Medicamen Biotech Limited has submitted copies of newspaper clippings showing publication of its audited financial results for the quarter and full year ended March 31, 2025. The results were published in the Financial Express and Jansatta on May 31, 2025, as required under SEBI listing rules. For Q4 FY25, revenue from operations rose to about Rs 7,123.7 lakhs from Rs 5,968.5 lakhs a year ago, and the company posted a net profit of Rs 1,090 lakhs versus a loss of Rs 257.8 lakhs in Q4 FY24. For the full year FY25, revenue stood at Rs 22,273 lakhs with a net profit of Rs 1,082.7 lakhs, compared to a net loss of Rs 824.4 lakhs in FY24. The board had approved these results on May 30, 2025 on the recommendation of the audit committee.